Chabio&Diostech Co., Ltd is a Korea-based company mainly engaged in the bio business. The Company operates in two business segments: bio segment and optical segment. Its bio segment engages in the development of stem cell therapies, which are used for heart disease, brain nervous system disease, diabetes, liver disease and others, provision of stem cell storage services; production of cosmetics and cosmetic raw materials, as well as distribution of medical devices and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phones, close circuit televisions (CCTVs), cameras and others. As of December 31, 2011, the Company had 10 affiliated companies. On January 25, 2011, the Company acquired a 71.83% stake in a Korea-based company, engaged in the development of hepatitis B vaccines and immunity reinforcing agents.
(Source: ARS)